As part of our Funding & Reimbursement Shorts series Community Pharmacy England’s in-house Drug Tariff and funding experts have created a new video providing guidance on how handling ‘FS’ endorsed prescriptions for free supply of sexual health treatments. In our latest video, Mitesh Bhudia and Gemma Hackett from our Dispensing and Supply Team, discuss the
Read moreDrug alert number: EL (25)A/04 Date issued: 30 January 2025 Bristol Laboratories Limited is recalling the batches specified in the table as a precautionary measure due to possible microbial contamination. Amlodipine Bristol Lab 2.5 mg Tablets, PL 17907/0435 SNOMED Code: 38095611000001108 Batch Number Expiry Date Pack Size First Distributed MF23016 July 2025 28 29/9/2023 MF23017
Read moreFollowing discussions between Community Pharmacy England and the Department of Health and Social Care (DHSC) regarding medicine pricing issues reported by pharmacy owners, the Department has today (30/01/2025) announced the following list of price concessions for January 2025. Following representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health
Read moreYesterday, Community Pharmacy England joined with the British Dental Association, British Medical Association, Optometric Fees Negotiating Committee and the Association for Primary Care Audiology Providers, to host a ‘Future of Primary Care’ Parliamentary drop-in event. The event, sponsored by pharmacy APPG Chair, Steve Race MP, was well attended with 40 MPs and their staff present
Read moreCommunity pharmacies received strong backing yesterday in Parliament, with numerous Peers speaking out in support of the sector, recognising their vital role in community healthcare and raising the urgent funding challenges they face. Discussions in the House of Lords included expressing a desire to expand community pharmacies’ role in public health and the Government’s commitment
Read moreThe Drug Tariff Preface published monthly, lists additions, deletions and other changes to products listed in the Drug Tariff. Below is a summary of the changes coming into effect from 1 February 2025. Key g Special container – This product is a special container and should be dispensed in its complete original pack size. n Item requiring reconstitution
Read moreA new Medicines and Healthcare products Regulatory Agency (MHRA) Drug Safety Update (Vol 18 Issue 6 January 2025) has been published and includes articles on: GLP-1 and dual GIP/GLP-1 receptor agonists: potential risk of pulmonary aspiration during general anaesthesia or deep sedation Letters and medicine recalls sent to healthcare professionals in December 2024 To see the latest
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Memantine (Valios®) 5mg orodispersible tablets sugar free MSN/2025/005 Tier 2 – medium impact Date of issue: 28th January 2025 Memantine (Valios®) 5mg orodispersible tablets sugar free are out of stock until late April 2025. Memantine (Valios®) 5 mg/10 mg/15 mg/20 mg
Read moreThe Department of Health and Social Care (DHSC) has entered into consultation with Community Pharmacy England (CPE) regarding the 2024/25 and 2025/26 funding contractual framework. The discussions will set the future direction for community pharmacy as it plays a vital role in supporting delivery of the reforms set out in the government’s Plan for Change.
Read moreFollowing representations made by Community Pharmacy England on behalf of community pharmacy owners, the Department of Health and Social Care (DHSC) has agreed to retrospectively adjust the reimbursement price of Gaviscon Infant oral powder 15 dual dose sachets for EPS prescriptions dispensed between May 2023 to November 2024. The term ‘dual dose sachets’ was updated to
Read more
